Tumor cell plasticity and angiogenesis in human melanomas

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Mihic Probst, Daniela ^a   Ikenberg, Kristian ^a   Tinguely, Marianne ^a   Schraml, Peter ^a   Behnke, Silvia ^a   Seifert, Burkhardt ^b   Civenni, Gianluca ^c   Sommer, Lukas ^c   Moch, Holger ^a   Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 4; GLUCOSE TRANSPORTER 1; GREEN FLUORESCENT PROTEIN; MECA32 PROTEIN; MELAN A; MELANIN; MOLECULAR MARKER; MONOCLONAL ANTIBODY D2-40; MONOCLONAL ANTIBODY HMB 45; UNCLASSIFIED DRUG; TUMOR MARKER; TUMOR PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CAPILLARY FORMATION; CARCINOGENESIS; CELL HYPOXIA; CELL STRUCTURE; CHROMOSOME 17; CONTROLLED STUDY; FEMALE; GENE; HER2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MELANOMA; MELANOMA CELL; METASTASIS; MICROMETASTASIS; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR CELL; TUMOR CELL LINE; TUMOR CELL PLASTICITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VASCULAR MIMICRY; VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL STRAIN HEK293; CLINICAL TRIAL; METABOLISM; NUDE MOUSE; PATHOLOGY; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; GLUCOSE TRANSPORTER TYPE 1; HEK293 CELLS; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858604134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033571     Document Type: Article

References (44)

1. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, et al. (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355: 1307-1317.
2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622-3634.
3. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198.
4. Stacker SA, Farnsworth RH, Karnezis T, Shayan R, Smith DP, et al. (2007) Molecular pathways for lymphangiogenesis and their role in human disease. Novartis Found Symp 281: 38-43; discussion 44-53, 208-209.
5. Tobler NE, Detmar M, (2006) Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. J Leukoc Biol 80: 691-696.
6. Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, et al. (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18: 1232-1242.
7. Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, et al. (2006) Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 66: 10365-10376.
8. Harrell MI, Iritani BM, Ruddell A, (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170: 774-786.
9. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099.
10. Hirakawa S, Fujii S, Kajiya K, Yano K, Detmar M, (2005) Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood 105: 2392-2399.
11. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540.
12. Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, et al. (2006) Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19: 290-302.
13. Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, et al. (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68: 650-656.
14. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, et al. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752.
15. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, et al. (2002) Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 62: 560-566.
16. Sun B, Zhang S, Zhao X, Zhang W, Hao X, (2004) Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25: 1609-1614.
17. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, et al. (2002) Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50: 189-201.
18. Zhang S, Zhang D, Sun B, (2007) Vasculogenic mimicry: current status and future prospects. Cancer Lett 254: 157-164.
19. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, et al. (2002) Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246.
20. Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, et al. (2001) Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 7: 473-477.
21. Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, et al. (2001) Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 61: 3250-3255.
22. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, et al. (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 97: 14608-14613.
23. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, et al. (2002) Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62: 665-668.
24. Butler TP, Gullino PM, (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35: 512-516.
25. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature.
26. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature.
27. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
28. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, et al. (2011) Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-Term Growth. Cancer Res.
29. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
30. Follenzi A, Naldini L, (2002) Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 346: 454-465.
31. Yun SJ, Gimotty PA, Hwang WT, Dawson P, Van Belle P, et al. (2011) High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma. Am J Surg Pathol 35: 235-242.
32. Folkman J, Kalluri R, (2004) Cancer without disease. Nature 427: 787.
33. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, et al. (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162: 1951-1960.
34. Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V, Colpaert CG, et al. (2006) Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Br J Cancer 95: 1362-1366.
35. Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van Dam P, et al. (2007) Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 13: 5391-5397.
36. Guidi AJ, Berry DA, Broadwater G, Perloff M, Norton L, et al. (2000) Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 92: 486-492.
37. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, et al. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95: 4607-4612.
38. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, et al. (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380.
39. Roskoski R Jr, (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62: 179-213.
40. Yang L, Chen G, Mohanty S, Scott G, Fazal F, et al. (2011) GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression. Cancer Res.
41. Luan Q, Sun J, Li C, Zhang G, Lv Y, et al. (2011) Mutual enhancement between heparanase and vascular endothelial growth factor: A novel mechanism for melanoma progression. Cancer Lett 308: 100-111.
42. Sommer L, (2005) Checkpoints of melanocyte stem cell development. Sci STKE 2005: pe42.
43. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, et al. (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100: 1389-1398.
44. Liotta LA, Kleinerman J, Saidel GM, (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004.